CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,500 shares at an average $19.45 ($204,260)
- 4 Open-market buy Director bought 5,000 shares at $20.70 ($103,500)
- 4 Planned sale Chief Scientific Officer sold 9,438 shares at $21.64 ($204,238)
- 4 Planned sale Chief Financial Officer sold 65,000 shares at an average $21.92 ($1,424,916)
- 4 Gift Chief Scientific Officer gave 6,291 shares (gift)
- 4 Open-market buy President and CEO bought 25,450 shares at $19.67 ($500,602)
- 4 Open-market sale Director sold 65,000 shares at an average $20.55 ($1,335,626)
- 4 Open-market buy Director bought 2,000 shares at an average $21.84 ($43,670)
- 4 Open-market buy President and CEO bought 4,729 shares at $21.15 ($100,018)
- 4 Planned sale Director sold 383,200 shares at an average $21.74 ($8,330,080)
- 4 Gift Chief Scientific Officer gave 3,000 shares (gift)
- 4 Open-market buy President and CEO bought 7,278 shares at $20.48 ($149,053)
- 4 Open-market buy Chief Technical Officer bought 10,000 shares at $20.49 ($204,900)
- 4 Open-market buy President and CEO bought 46,511 shares at $21.50 ($999,987)
- 4 Option exercise Chief Scientific Officer acquired 22,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 10 · 187 filings